Sage Infusion LLC — SEC Form D Filing

Sage Infusion LLC filed an SEC Form D on March 23, 2026, reporting $11.75M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
March 23, 2026
Amount reported
$11.75M
Industry
Health Care
Website
https://sageinfusion.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: FLORIDA

Problem

Patients need convenient and affordable access to infusion therapy without the hassle or costs typically associated with hospitals.

Solution

Sage Infusion offers a patient-focused infusion therapy experience with upfront pricing, individualized cost estimates, and flexible appointment options in a comfortable and serene environment.

Verdict

Investors said yes because Sage Infusion presented a clear alternative to traditional hospital-based infusion therapy, not because of any distinct competitive advantages. They implicitly bet on the growing demand for convenient and cost-effective health care solutions driven by consumer preferences. However, the limited upside lies in the challenge to scale this model against entrenched players who often have established networks and trust, putting pressure on the durability of this narrative over the long term.

Source: SEC EDGAR Form D filing